These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
112 related articles for article (PubMed ID: 32014488)
1. Vasoactive intestinal peptide infusion reverses existing renal interstitial fibrosis via a blood pressure independent mechanism in the rat. Duggan KA; Hodge G; Chen J; Trajanovska S; Hunter T Eur J Pharmacol; 2020 Apr; 873():172979. PubMed ID: 32014488 [TBL] [Abstract][Full Text] [Related]
2. Vasoactive intestinal peptide infusion reverses existing myocardial fibrosis in the rat. Duggan KA; Hodge G; Chen J; Hunter T Eur J Pharmacol; 2019 Nov; 862():172629. PubMed ID: 31449808 [TBL] [Abstract][Full Text] [Related]
3. Myocardial vasoactive intestinal peptide and fibrosis induced by nitric oxide synthase inhibition in the rat. Ye VZ; Hodge G; Yong JL; Duggan KA Acta Physiol Scand; 2003 Dec; 179(4):353-60. PubMed ID: 14656372 [TBL] [Abstract][Full Text] [Related]
4. Early myocardial fibrosis is associated with depletion of vasoactive intestinal peptide in rat heart. Ye VZ; Hodge G; Yong JL; Duggan KA Exp Physiol; 2002 Sep; 87(5):539-46. PubMed ID: 12481928 [TBL] [Abstract][Full Text] [Related]
5. [Slowing the progression of chronic renal insufficiency with captopril in rats with spontaneous arterial hypertension and adriamycin nephropathy]. Jovanović DB; Jovović Dj; Varagić J; Dimitrijević J; Dragojlović Z; Djukanović L Srp Arh Celok Lek; 2002; 130(3-4):73-80. PubMed ID: 12154518 [TBL] [Abstract][Full Text] [Related]
6. Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide prevent inducible nitric oxide synthase transcription in macrophages by inhibiting NF-kappa B and IFN regulatory factor 1 activation. Delgado M; Munoz-Elias EJ; Gomariz RP; Ganea D J Immunol; 1999 Apr; 162(8):4685-96. PubMed ID: 10202009 [TBL] [Abstract][Full Text] [Related]
7. Tubulointerstitial injury of Thy-1 nephritis in uninephrectomized stroke-prone spontaneously hypertensive rats. Wang PR; Masuda Y; Kitamura H; Yamanaka N J Nippon Med Sch; 2001 Aug; 68(4):301-9. PubMed ID: 11505277 [TBL] [Abstract][Full Text] [Related]
8. [Protective effects of vasoactive intestinal peptide on septic shock rats]. Qiu JF; Zhang ZQ; Chen W; Wu ZY Zhonghua Wai Ke Za Zhi; 2007 Feb; 45(3):196-9. PubMed ID: 17498382 [TBL] [Abstract][Full Text] [Related]
9. Stimulatory effect of vasoactive intestinal peptide (VIP) on cyclic AMP production in rat peritoneal macrophages. Segura JJ; Guerrero JM; Goberna R; Calvo JR Regul Pept; 1992 Feb; 37(3):195-203. PubMed ID: 1372999 [TBL] [Abstract][Full Text] [Related]
10. VIP impairs acquisition of the macrophage proinflammatory polarization profile. Carrión M; Pérez-García S; Martínez C; Juarranz Y; Estrada-Capetillo L; Puig-Kröger A; Gomariz RP; Gutiérrez-Cañas I J Leukoc Biol; 2016 Dec; 100(6):1385-1393. PubMed ID: 27381006 [TBL] [Abstract][Full Text] [Related]
11. Impact of VIP and cAMP on the regulation of TNF-alpha and IL-10 production: implications for rheumatoid arthritis. Foey AD; Field S; Ahmed S; Jain A; Feldmann M; Brennan FM; Williams R Arthritis Res Ther; 2003; 5(6):R317-28. PubMed ID: 14680506 [TBL] [Abstract][Full Text] [Related]
12. Role of Ca2+ on vasoactive intestinal peptide-induced glucose and adenosine 3',5'-monophosphate production in the isolated perfused rat liver. Saito K; Yamatani K; Manaka H; Takahashi K; Tominaga M; Sasaki H Endocrinology; 1992 Apr; 130(4):2267-73. PubMed ID: 1372240 [TBL] [Abstract][Full Text] [Related]
13. Norcantharidin attenuates tubulointerstitial fibrosis in rat models with diabetic nephropathy. Li Y; Chen Q; Liu FY; Peng YM; Hou T; Duan SB; Li J; Luo JH; Sun L; Ling GH Ren Fail; 2011; 33(2):233-41. PubMed ID: 21332346 [TBL] [Abstract][Full Text] [Related]
14. Neuropeptide control of rat gastric mucosal blood flow. Increase by calcitonin gene-related peptide and vasoactive intestinal polypeptide, but not substance P and neurokinin A. Holzer P; Guth PH Circ Res; 1991 Jan; 68(1):100-5. PubMed ID: 1702035 [TBL] [Abstract][Full Text] [Related]
15. Shedding of membrane-bound CD14 from lipopolysaccharide-stimulated macrophages by vasoactive intestinal peptide and pituitary adenylate cyclase activating polypeptide. Delgado M; Leceta J; Abad C; Martinez C; Ganea D; Gomariz RP J Neuroimmunol; 1999 Sep; 99(1):61-71. PubMed ID: 10496178 [TBL] [Abstract][Full Text] [Related]
16. Effects of indomethacin and (+/-)-propranolol on the cardiovascular and renin responses to vasoactive intestinal polypeptide (VIP) infusion in man. Unwin RJ; Reed T; Thom S; Calam J; Peart WS Br J Clin Pharmacol; 1987 May; 23(5):523-8. PubMed ID: 3297124 [TBL] [Abstract][Full Text] [Related]
17. [Effect of vasoactive intestinal peptide on defecation and VIP-cAMP-PKA-AQP3 signaling pathway in rats with constipation]. Zhou Y; Wang Y; Zhang H; Yan S; Wang B; Xie P Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2016 Nov; 41(11):1175-1180. PubMed ID: 27932763 [TBL] [Abstract][Full Text] [Related]
18. Influence of vasoactive intestinal polypeptide on net water flux and cyclic adenosine 3',5'-monophosphate formation in the rat jejunum. Beubler E Naunyn Schmiedebergs Arch Pharmacol; 1980 Sep; 313(3):243-7. PubMed ID: 6253842 [TBL] [Abstract][Full Text] [Related]